Skip to main content

ADVERTISEMENT

allograft

Case Series
06/01/2020
Michael S. Flood
Blake Weeks
Kenneth O. Anaeme
Heather Aguirre
Kimberlee B. Hobizal
Sandi E. Jiongco
Robert J. Klein
Andrew Lemoi
Rafael Rafols
Adam S. Landsman
The aim of this case series is to study deep wounds treated with the bioactive human skin allograft to better understand how it is used in real-world patients and discuss its mechanism of action.
The aim of this case series is to study deep wounds treated with the bioactive human skin allograft to better understand how it is used in real-world patients and discuss its mechanism of action.
The aim of this case series is...
06/01/2020
Wounds
Case Report
07/30/2019
Tania Benjamin
Rachel L Wattier
William Dominic
The authors report allografting in addition to systemic antifungals as an option for critically ill preterm neonates to decrease blood loss and risk of donor site infection.
The authors report allografting in addition to systemic antifungals as an option for critically ill preterm neonates to decrease blood loss and risk of donor site infection.
The authors report allografting...
07/30/2019
Wounds
Case Series
07/29/2019
Introduction: There are currently 30.3 million Americans diagnosed as having diabetes, and a quarter of them will develop a diabetic foot ulcer in their lifetime. Individuals with diabetes frequently develop peripheral vascular disease (PVD)...
Introduction: There are currently 30.3 million Americans diagnosed as having diabetes, and a quarter of them will develop a diabetic foot ulcer in their lifetime. Individuals with diabetes frequently develop peripheral vascular disease (PVD)...
Introduction: There are...
07/29/2019
Wounds
Case Series
10/17/2018
BACKGROUND: Allogenic adipose tissue has been used as a filler in soft-tissue defects as a noninvasive alternative to surgical grafting. Advantages of the use of adipose tissue include the presence of extracellular matrix and growth factors...
BACKGROUND: Allogenic adipose tissue has been used as a filler in soft-tissue defects as a noninvasive alternative to surgical grafting. Advantages of the use of adipose tissue include the presence of extracellular matrix and growth factors...
BACKGROUND: Allogenic adipose...
10/17/2018
Wounds
Clinical Research Poster
10/10/2018
OBJECTIVE: To determine the safety and effectiveness of dehydrated human umbilical cord allograft for the treatment of chronic, nonhealing diabetic foot ulcers (DFUs).  MATERIALS AND METHODS: An institutional review board-approved,...
OBJECTIVE: To determine the safety and effectiveness of dehydrated human umbilical cord allograft for the treatment of chronic, nonhealing diabetic foot ulcers (DFUs).  MATERIALS AND METHODS: An institutional review board-approved,...
OBJECTIVE: To determine the...
10/10/2018
Wounds
Abstracts
10/01/2018
Wounds Editorial Staff
10/01/2018
Wounds
Case Series
08/01/2018
Vita Boyar
Colleen Galiczewski
This case series of 4 neonatal patients describes the experience and efficacy of using a dehydrated human amniotic membrane allograft (dHAMA) in the treatment of severe extravasation injuries.
This case series of 4 neonatal patients describes the experience and efficacy of using a dehydrated human amniotic membrane allograft (dHAMA) in the treatment of severe extravasation injuries.
This case series of 4 neonatal...
08/01/2018
Wounds
Rapid Communication
03/19/2018
Matthew Regulski
The aim of this study is to evaluate a viable human amnion membrane allograft (vHAMA) for the treatment of chronic nonhealing wounds in elderly patients (aged > 65 years) with multiple comorbidities.
The aim of this study is to evaluate a viable human amnion membrane allograft (vHAMA) for the treatment of chronic nonhealing wounds in elderly patients (aged > 65 years) with multiple comorbidities.
The aim of this study is to...
03/19/2018
Wounds
Clinical Cases
11/21/2017
Dr. Matthew Regulski presents his poster, “Utilization of a Viable Human Amnion Membrane Allograft in Elderly Patients With Chronic Lower Extremity Wounds of Various Etiologies,” which was exhibited at the 2017 SAWC Fall in Las Vegas, NV.
Dr. Matthew Regulski presents his poster, “Utilization of a Viable Human Amnion Membrane Allograft in Elderly Patients With Chronic Lower Extremity Wounds of Various Etiologies,” which was exhibited at the 2017 SAWC Fall in Las Vegas, NV.
Dr. Matthew Regulski presents...
11/21/2017
Wounds
Current Research
09/15/2014
Wounds